CAH

- If successful, BridgeBio’s investigational gene therapy BBP-631 would be the first therapy for CAH to restore the body’s hormone and steroid balance by enabling people with CAH to make their own cortisol and aldosterone -Initial Phase…

Some are just hackneyed. Others signal something, but mean nothing specific. Others nod to a shiny virtual future, which they may or may not deliver. Some are just irritating.As the year comes to a close, CIO Journal asked technology…

Cardinal Health Inc. plans to test the use of drones to speed delivery of pills, inhalers and other items to U.S. pharmacies, a move the healthcare-supplies distributor said could also…